Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Cerity Partners LLC Acquires 62,426 Shares of AbbVie Inc. $ABBV - Markets Daily
Focus Partners Advisor Solutions LLC Buys 13,993 Shares of AbbVie Inc. $ABBV - Markets Daily
Focus Partners Advisor Solutions LLC Has $11.48 Million Stock Position in AbbVie Inc. $ABBV
AbbVie (NYSE:ABBV) Shares Down 1.9% - What's Next? - Markets Daily
Promising Medical Stocks To Research - June 8th - Stock Observer
Dividend Stocks To Research - June 8th - Daily Political
LPL Financial LLC Buys 119,704 Shares of AbbVie Inc. $ABBV
O Shaughnessy Asset Management LLC Boosts Holdings in AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Shares Sold by Erste Asset Management GmbH
AbbVie Inc. $ABBV Shares Acquired by Fiera Capital Corp
AbbVie (NYSE:ABBV) - Stock Analysis - Simply Wall St
Top Pharmaceutical Stocks To Watch Today - June 7th - Zolmax
Forget Wall Street's Ultimate Pharma Value Trap: Here Is a Far Better Stock to Buy Right Now
Dividend Stocks To Research - June 7th - Daily Political
Capital Research Global Investors Has $5.81 Billion Stake in AbbVie Inc. $ABBV - Zolmax
Capital International Inc. CA Has $69.41 Million Holdings in AbbVie Inc. $ABBV - Zolmax
ING Groep NV Trims Stock Position in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by Dearborn Partners LLC
Wall Street Zen Downgrades AbbVie (NYSE:ABBV) to Buy
Dearborn Partners LLC Reduces Position in AbbVie Inc. $ABBV - Daily Political
AbbVie Inc. $ABBV Shares Acquired by Capital World Investors - Daily Political
Dividend Stocks To Follow Today - June 6th - Markets Daily
AbbVie (ABBV) Valuation Check After New Cancer And Migraine Drug Approvals
Dividend Stocks To Follow Today - June 6th - Stock Observer
Best Medical Stocks To Follow Now - June 5th - Markets Daily
Assessing AbbVie (ABBV) Valuation After Fresh Regulatory Wins In Migraine And Blood Cancer
AbbVie (ABBV) Announces European Commission's Approval of AQUIPTA®
AbbVie (NYSE:ABBV) Trading 1.2% Higher - What's Next? - Daily Political
Pharmaceutical Stocks To Consider - June 5th - Stock Observer
AbbVie Inc. $ABBV Shares Purchased by Westfield Capital Management Co. LP
Vise Technologies Inc. Acquires 25,198 Shares of AbbVie Inc. $ABBV
WCG Wealth Advisors LLC Buys Shares of 17,087 AbbVie Inc. $ABBV
12,757 Shares in AbbVie Inc. $ABBV Bought by Total Wealth Planning & Management Inc.
J.W. Cole Advisors Inc. Cuts Stake in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Bought by Prestige Wealth Management Group LLC - Stock Observer
AbbVie (NYSE:ABBV) Shares Unloaded Rep. Josh Gottheimer
Clifford Swan Investment Counsel LLC Sells 3,532 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Stock Unloaded Rep. Josh Gottheimer - Stock Observer
NICE Endorses AbbVie's Elahere for Treating Ovarian Cancer, ETPharma
Elahere's NHS Approval Tests AbbVie's Oncology Expansion And Investor Thesis
AbbVie (NYSE:ABBV) Shares Up 3.5% - Here's What Happened
Aldeyra Therapeutics Eyes FDA Feedback as Dry Eye Drug Faces Make-or-Break Moment - Stock Observer
5 Best Cheap Stocks to Buy for Beginners
Greenspring Advisors LLC Grows Stake in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by TD Asset Management Inc
Top Medical Stocks To Research - June 4th - Daily Political
AbbVie Inc. $ABBV Shares Bought by Cibc World Market Inc.
Promising Medical Stocks To Research - June 3rd - Zolmax
Bank of New York Mellon Corp Raises Stock Holdings in AbbVie Inc. $ABBV - Zolmax
AbbVie Delivers 400% Returns Beating The S&P 500 by 139% - AOL
Top 5 High-Yield Dividend Stocks for Income Investors in 2026
This Is What a $1 Million Dividend Portfolio Pays After Taxes
The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of AQUIPTA For Acute Migraine
AbbVie Inc. $ABBV Stock Holdings Increased by BNP Paribas - Stock Observer
Revenue Rises 27.5%; AbbVie Pact Marks Key FY26 Milestone
COFG Advisors LLC Invests $4.09 Million in AbbVie Inc. $ABBV - Stock Observer
AbbVie (NYSE:ABBV) Shares Up 1.4% - Here's What Happened - Daily Political
Consensus meta-analysis of genome-wide association studies for Alzheimer's disease and related dementias
Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells
AbbVie (ABBV) to Attend Goldman Sachs Global Healthcare Conference
Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic - AOL
AbbVie Inc. (ABBV) Announces EC Authorization of Expanded Label for VENCLYXTO®
Is AbbVie Inc. (ABBV) Expanding Its Oncology Pipeline With New BPDCN Treatment Approval?
17,902 Shares in AbbVie Inc. $ABBV Purchased by COFG Advisors LLC
Glenmark Pharmaceuticals Ltd (BOM:532296) Q4 2026 Earnings Call Highlights: Strong Revenue ...
Access to CAR-T cell therapy in Central and Eastern Europe: persistent barriers and inequalities as of October/November 2025
Promising Pharmaceutical Stocks To Follow Now - June 1st - Zolmax
Natera And 2 Other Companies That May Be Trading Below Their Estimated Value
AbbVie Inc. $ABBV Shares Bought by Hillsdale Investment Management Inc.
AbbVie Inc. (NYSE:ABBV) Given Consensus Recommendation of "Moderate Buy" by Brokerages - Daily Political
Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM)
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
Privacy preserving digital platform for patient reported outcomes in inflammatory bowel disease
Botulinum Toxin Drugs Market Demand and Future Opportunities - Express Press Release Distribution
AbbVie Inc. $ABBV Shares Bought by MUFG Securities EMEA plc
Railway Pension Investments Ltd Has $196.44 Million Stock Holdings in AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Shares Sold by Welch & Forbes LLC - Stock Observer
AbbVie Inc. $ABBV Position Increased by MUFG Securities EMEA plc - Daily Political
Investment Analysts' Upgrades for May 30th (A, ABBV, ACA, AFCG, AKAN, ALLR, ALRS, ASUR, AXIA, BILL) - Stock Observer
SBI Okasan Asset Management Co.Ltd. Acquires New Shares in AbbVie Inc. $ABBV - Zolmax
Intech Investment Management LLC Sells 2,467 Shares of AbbVie Inc. $ABBV - Stock Observer
SBI Okasan Asset Management Co.Ltd. Buys New Holdings in AbbVie Inc. $ABBV - Daily Political
AbbVie (NYSE:ABBV) Raised to Strong-Buy at Wall Street Zen
Norges Bank Takes $5.87 Billion Position in AbbVie Inc. $ABBV - Daily Political
Eurizon Capital SGR S.p.A. Acquires Shares of 1,554,089 AbbVie Inc. $ABBV - Daily Political
AbbVie (ABBV) Expands Venclyxto Label for Chronic Lymphocytic Leukemia Treatment
VYM Climbs 26% In a Year While Its Core Dividend Payers Extend Their Streaks
AbbVie Stock: Is ABBV Outperforming the Healthcare Sector?
Rothschild Investment LLC Reduces Position in AbbVie Inc. $ABBV - Zolmax
AbbVie's VENCLYXTO Label Gets EU Approval For Chronic Lymphocytic Leukemia Treatment
Assessing AbbVie (ABBV) Valuation After FDA Approval Of Decnupaz For Ultra Rare Blood Cancer
Best Pharmaceutical Stocks To Research - May 29th - Daily Political
AbbVie News
US Stock Market Correction: Banks Warn of Lingering Risks Amidst Shifting Momentum
Bond Market Re-evaluation Amid Geopolitical Shifts and Inflationary Pressures
SpaceX IPO Momentum Builds: MSCI Inclusion Expected to Drive Significant Inflows
Intel Foundry Poised for Major Gains with Potential Google and Nvidia Partnerships
US CPI Preview: Higher Inflation Could Reinforce Fed Rate-Hike Bets
CFD Trading Strategies: How to Cash In on the World Cup Stock Market Curse with CFD Shorts
Latest news
Show moreEconomic Volatility, Inflation Fears, and AI-Driven Stock Market Dynamics
India's Gold Smuggling Surges Post Tariff Hike, Shadow Market Dominates
Pakistan: US-Iran Peace Deal Unlikely Soon Amid Israeli Ceasefire Violations
Hormuz Strait Disruption: Market Expectations, Geopolitical Triggers, and the Oil Price Paradox
Bank of Japan May Halt Bond Purchases After 2027, Signaling Pivot on Quantitative Tightening
AI IPO Race Intensifies: OpenAI and Anthropic File Confidentially, SpaceX Gears Up for Market
